Cargando…

AS3MT Polymorphism: A Risk Factor for Epilepsy Susceptibility and Adverse Drug Reactions to Valproic Acid and Oxcarbazepine Treatment in Children From South China

Epilepsy is a common neurologic disorder characterized by intractable seizures, involving genetic factors. There is a need to develop reliable genetic markers to predict the risk of epilepsy and design effective therapies. Arsenite methyltransferase (AS3MT) catalyzes the biomethylation of arsenic an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Xiaomei, Chen, Yuna, Lu, Jieluan, Li, Wenzhou, Li, Xi, Guo, Huijuan, Chen, Qing, Yang, Yanxia, Xia, Hanbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8661122/ https://www.ncbi.nlm.nih.gov/pubmed/34899152 http://dx.doi.org/10.3389/fnins.2021.705297

Ejemplares similares

Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy
por: Lu, Jieluan, et al.
Publicado: (2021)

Association of ABCB1 Polymorphisms with Efficacy and Adverse Drug Reactions of Valproic Acid in Children with Epilepsy
por: Zhu, Jiahao, et al.
Publicado: (2023)

Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of ABCB1 gene polymorphism
por: Shen, Xianhuan, et al.
Publicado: (2022)

Genetic Polymorphism of ADORA2A Is Associated With the Risk of Epilepsy and Predisposition to Neurologic Comorbidity in Chinese Southern Children
por: Fan, Xiaomei, et al.
Publicado: (2020)

Cutaneous adverse drug reactions induced by Oxcarbazepine
por: Hsiao, Yi-Hsin, et al.
Publicado: (2014)

Oxcarbazepine-induced tardive dyskinesia: A rare adverse reaction
por: Hergüner, M. Özlem, et al.
Publicado: (2010)

Reintroduction of oxcarbazepine after allergic reaction in two pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2021)

Why should we monitor for hematologic adverse drug reactions to oxcarbazepine?
por: Jang, Gwang Cheon
Publicado: (2019)

Analysis of Adverse Drug Reactions with Carbamazepine and Oxcarbazepine at a Tertiary Care Hospital
por: Lee, Jung Eun, et al.
Publicado: (2020)

Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Comparison of Cognitive Effects of Lamotrigine and Oxcarbazepine in Epilepsy Patients
por: Seo, Jong-Geun, et al.
Publicado: (2007)

Effect of Oxcarbazepine on Background EEG Activity and Cognition in Epilepsy
por: Kim, Sung Min, et al.
Publicado: (2013)

Symptomatology of carbamazepine‐ and oxcarbazepine‐induced hyponatremia in people with epilepsy
por: Berghuis, Bianca, et al.
Publicado: (2021)

Severe recurrent hypothermia in an elderly patient with refractory mania associated with atypical antipsychotic, valproic acid and oxcarbazepine therapy
por: Ajayi, Oluwadamilare O, et al.
Publicado: (2017)

Oxcarbazepine monotherapy in children with benign epilepsy with centrotemporal spikes improves quality of life
por: Liu, Wan-Ting, et al.
Publicado: (2020)

Oxcarbazepine and Hyponatremia
por: Čiauškaitė, Julija, et al.
Publicado: (2022)

Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
por: Gómez, E., et al.
Publicado: (2023)

Cognitive Effects of Low-dose Topiramate Compared with Oxcarbazepine in Epilepsy Patients
por: Kim, Sun-Young, et al.
Publicado: (2006)

Effect of Oxcarbazepine on Language Function in Patients With Newly Diagnosed Pediatric Epilepsy
por: Han, Min Jeong, et al.
Publicado: (2023)

Modulation of Antioxidant Enzymatic Activities by Certain Antiepileptic Drugs (Valproic Acid, Oxcarbazepine, and Topiramate): Evidence in Humans and Experimental Models
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2013)

Evaluation of Factors Impacting the Efficacy of Single or Combination Therapies of Valproic Acid, Carbamazepine, and Oxcarbazepine: A Longitudinal Observation Study
por: Peng, Qilin, et al.
Publicado: (2021)

EEG-Driven Prediction Model of Oxcarbazepine Treatment Outcomes in Patients With Newly-Diagnosed Focal Epilepsy
por: Wang, Bin, et al.
Publicado: (2022)

Oxcarbazepine-induced systemic lupus erythematosus: A rare and serious adverse drug reaction to a common anticonvulsant
por: Sinha, Anwita, et al.
Publicado: (2021)

Association of LEPR and ANKK1 Gene Polymorphisms with Weight Gain in Epilepsy Patients Receiving Valproic Acid
por: Li, Hongliang, et al.
Publicado: (2015)

Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Effectiveness and Safety of Oxcarbazepine vs. Levetiracetam as Monotherapy for Infantile Focal Epilepsy: A Longitudinal Cohort Study
por: Zhao, Binyang, et al.
Publicado: (2022)

Uncontrolled headache induced by oxcarbazepine
por: Piovesan, Elcio Juliato, et al.
Publicado: (2007)

Corrigendum: Comparison of the effectiveness and safety of perampanel and oxcarbazepine as monotherapy in children and adolescents with newly diagnosed focal epilepsy
por: Yi, Jia-Qin, et al.
Publicado: (2023)

Efficacy and safety of oxcarbazepine in the treatment of children with epilepsy: a meta-analysis of randomized controlled trials
por: Geng, Hua, et al.
Publicado: (2017)

Effects of levetiracetam and oxcarbazepine monotherapy on intellectual and cognitive development in children with benign epilepsy with centrotemporal spikes
por: Suo, Gui-hai, et al.
Publicado: (2021)

A Comparative Study of the Effects of Valproate and Oxcarbazepine on Sexual Function, Sperm Quality, and Sex Hormones in Males with Epilepsy
por: Guo, Yi, et al.
Publicado: (2021)

Expression of Multidrug Resistance Genes in Peripheral Blood of Patients with Refractory Epilepsy and the Reverse Effect of Oxcarbazepine on Its Expression
por: JI, Jinming, et al.
Publicado: (2018)

Implementation of HLA-B*15:02 Genotyping as Standard-of-Care for Reducing Carbamazepine/Oxcarbazepine Induced Cutaneous Adverse Drug Reactions in Thailand
por: Tiwattanon, Kanyawan, et al.
Publicado: (2022)

Oxcarbazepine May Be Useful in Sydenham Chorea
por: Işıkay, Sedat, et al.
Publicado: (2021)

Levetiracetam versus Oxcarbazepine as monotherapy in newly diagnosed focal epilepsy: A systematic review and meta‐analysis
por: Kharel, Sanjeev, et al.
Publicado: (2022)

Valproic acid-induced hyperammonemic encephalopathy – a potentially fatal adverse drug reaction
por: Sousa, Carla
Publicado: (2013)

Erythema Multiforme Major Associated With Community-Acquired Pneumonia: Lessons From a Case Report
por: Fan, Xiaomei, et al.
Publicado: (2021)

Effects of Oxcarbazepine and Levetiracetam on Calcium, Ionized Calcium, and 25-OH Vitamin-D3 Levels in Patients with Epilepsy
por: Aksoy, Duygu, et al.
Publicado: (2016)

A genome‐wide association study of sodium levels and drug metabolism in an epilepsy cohort treated with carbamazepine and oxcarbazepine
por: Berghuis, Bianca, et al.
Publicado: (2019)

606 Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine
por: Marinovic, Maria Angelica, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_598juvtusoo5dmdtol1292vptn